Connection

Marco Bongiovanni to Biomarkers, Tumor

Back to Details
This is a "connection" page, showing publications Marco Bongiovanni has written about Biomarkers, Tumor.
Marco Bongiovanni
Connection Strength
0.562
Biomarkers, Tumor
  1. Consistency and reproducibility of next-generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens. Cancer Cytopathol. 2019 05; 127(5):285-296.
    View in: PubMed
    Score: 0.101
  2. Mixed Adenoma Well-differentiated Neuroendocrine Tumor (MANET) of the Digestive System: An Indolent Subtype of Mixed Neuroendocrine-NonNeuroendocrine Neoplasm (MiNEN). Am J Surg Pathol. 2018 11; 42(11):1503-1512.
    View in: PubMed
    Score: 0.097
  3. Prediction of Occult Lymph Node Metastasis in Head and Neck Cancer with CD31 Vessel Quantification. Otolaryngol Head Neck Surg. 2019 02; 160(2):277-283.
    View in: PubMed
    Score: 0.096
  4. Notch-effector CSL promotes squamous cell carcinoma by repressing histone demethylase KDM6B. J Clin Invest. 2018 06 01; 128(6):2581-2599.
    View in: PubMed
    Score: 0.094
  5. Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations. Cancer Cytopathol. 2018 05; 126(5):317-325.
    View in: PubMed
    Score: 0.093
  6. Prediction of occult lymph node metastasis in squamous cell carcinoma of the oral cavity and the oropharynx using peritumoral Prospero homeobox protein 1 lymphatic nuclear quantification. Head Neck. 2016 09; 38(9):1407-15.
    View in: PubMed
    Score: 0.081
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.